摘要
化疗是晚期肺癌的主要治疗手段.第三代新药联合铂类的两药化疗方案是初治晚期非小细胞肺癌(NSCLC)的标准一线治疗方案,与最佳支持治疗比较,中位生存期延长2个月,1年生存率提高10%。
出处
《江西医药》
CAS
2009年第4期372-374,共3页
Jiangxi Medical Journal
参考文献10
-
1mith IE, O 'Brien ME, Talbot DC ,et al. Duration of chemotherapy in advanced non-small-cell lung cancer:A randomized trial of three versus six courses of mitomycin, vinblastine,and cisplatin. J Clin Oncol 2001,19:1356
-
2Socinski MA, Schell M J, Peterman A, et al. Phase Ⅲ trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage ⅢB/Ⅳ non-small-cell lung cancer. J Clin Oncol,2002,20:1335
-
3Goldie JH, Coldman AJ.A mathematical model for relating the drug Sensitivity of tumors to theirs spontaneous mutation rate.Caneer Treat Rep,1979,63(11-12):1727
-
4Day RS.Treatment sequencing,asymmetry,and uncertainty:protocol strategies for conrbination chemotherapy.Cancer Res,1986,46:3876
-
5Fidias P, Dakhil SR, Lyss AP et al. Updated report of a phase Ⅲ study of induction therapy with gemeitabine + carboplatin (GC) followed by either delayed vs. immediate second-line therapy with docetaxel (D) in advanced non-small cell lung cancer. J Clin Oncol, 2006,24(18 Suppl):7032
-
6Brodowicz T, Krzakowski M, Zwitter Met al. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase Ⅲ trial.Lung Cancer, 2006,52:155
-
7Ciuleanu TE, Brodowicz T, Belani CP, et al. Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase Ⅲ study. J Clin Oncol, 2008, 26: (Suppl ,abstr 8011)
-
8Hida T, Okamoto I, Kashii T, et al. Randomized phase Ⅲ study of platinum-doublet chemotherapy followed by gefitinib versus continued platinum-doublet chemotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of West Japan Thoracic Oncology Group trial (WJTOG). J Clin Oncol, 2008, 26: (suppl; abstr LBA8012)
-
9Westeel VI.Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.J Natl Cancer Inst, 2005,97:499
-
10Belani CP, Barstis J, La Rocca RV et al. Meta-analysis of weekly paclitaxel as maintenance therapy for advanced non-small cell lung cancer patients following initial chemotherapy. Lung Cancer, 2005,49 (suppl 2):S33
同被引文献32
-
1易峰涛,宋华志,李静.氩氦刀联合放疗治疗晚期肺肿瘤92例临床报告[J].生物医学工程研究,2005,24(2):125-125. 被引量:2
-
2牛立志,何卫兵,郭子倩,张述平,贺轶松,左建生,徐克成.经皮冷消融治疗局部进展型非小细胞肺癌[J].中国交通医学杂志,2006,20(2):138-139. 被引量:7
-
3陈书昌,陈建民,陈晔,李杏梅,洪安民.氩氦刀靶向冷冻联合化疗治疗中晚期非小细胞肺癌[J].山东医药,2007,47(15):56-57. 被引量:7
-
4Vuoristo MS,Vihinen P,Skytt(a) T,et al.Carboplatin and vinorelbine combined with subcutaneous interleukin-2 in metastatic melanoma with poor prognosis.Anticancer Res,2009,29:1755-1759.
-
5Grossi F,Aita M,Defferrari C,et al.Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer:a meta-analytical approach.Oncologist,2009,14:497-510.
-
6Pirker R,Pereira JR,Szczesna A,et al.Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX):an open-label randomised phase Ⅲ trial.Lancet,2009,373:1525-1531.
-
7Shimada K,Iwase K,Aono T,et al.A case of advanced mucinous cystadenocarcinoma of the pancreas with peritoneal dissemination responding to gemcitabine.Gan To Kagaku Ryoho,2009,36:995-998.
-
8Kamath A,Yoo D,Stuart OA,et al.Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer.Recent Pat Anticancer Drug Discov,2009,4:174-179.
-
9张积仁.美国Cryocare氩氦刀靶向治疗技术[J].Pioneer bioscience publishing Co 2003.
-
10冯华松,聂舟山,段蕴铀,李泳群,韩志海,张新红,孟激光,李毅,张燕,温居一.氩氦刀冷冻消融联合化疗治疗晚期非小细胞肺癌253例[J].中国肿瘤,2007,16(11):898-901. 被引量:17
引证文献3
-
1张建国,郑国宝.GP与NP方案对晚期非小细胞肺癌疗效的临床对比观察[J].肿瘤研究与临床,2010,22(9):634-635. 被引量:1
-
2李丁楠,张艳桥,李志伟,纪滨英,于丽娟,王晓红.氩氦刀联合化疗治疗中晚期非小细胞肺癌疗效观察[J].实用肿瘤学杂志,2011,25(4):310-314. 被引量:6
-
3陈国峰,黄海燕.CT引导下经皮冷循环微波刀联合化疗治疗周围型非小细胞肺癌的疗效观察[J].江西医药,2015,50(2):132-134.
二级引证文献7
-
1蒋志红,张燕.氩氦刀联合全身化疗对Ⅲb、Ⅳ期非小细胞肺癌患者的临床疗效及护理经验[J].中国现代手术学杂志,2014,18(3):234-237. 被引量:3
-
2李真斌,汤晓梅,易向军,孙勇,柯昌林,李瑶,王春福,陈轩.电子支气管镜介导冷冻治疗联合放化疗治疗中晚期中央型NSCLC的临床研究[J].中国医学创新,2014,11(36):27-29. 被引量:4
-
3韦英,李征,米登海,温志震,李忠信.氩氦刀联合放化疗方案治疗中晚期非小细胞肺癌的Meta分析[J].实用肿瘤杂志,2015,30(2):133-139. 被引量:10
-
4董振宇,郭志,于海鹏,刘影,张炜浩,杨雪玲.冷冻消融联合全身静脉化疗治疗晚期非小细胞肺癌的临床疗效及安全性评价[J].吉林大学学报(医学版),2015,41(4):839-845. 被引量:8
-
5段锋.GP和NP方案治疗晚期非小细胞肺癌临床疗效对比观察[J].中国现代药物应用,2016,10(2):208-209. 被引量:2
-
6公丽萍,毛本娣.中药联合氩氦刀局部冷冻治疗老年晚期非小细胞肺癌82例[J].河南中医,2016,36(7):1198-1200. 被引量:4
-
7张春阳,孟激光.氩氦靶向冷冻治疗联合化疗治疗晚期非小细胞肺癌的临床应用[J].中国临床医生杂志,2018,46(10):1142-1144. 被引量:5
-
1陈兴秀,毕益明,李全奎,李广起,郑东星.恩度联合长春瑞宾和奈达铂治疗非小细胞肺癌的临床研究[J].滨州医学院学报,2009,32(6):478-479. 被引量:3
-
2毕大鹏.替吉奥治疗晚期非小细胞肺癌的临床疗效[J].国际医药卫生导报,2017,23(5):708-710. 被引量:1
-
3文世民,何朗,郭翠华,别俊,胡欣,潘荣强,付曦.替吉奥治疗30例PS=2-3老年晚期胃癌临床观察[J].现代肿瘤医学,2011,19(10):2047-2049. 被引量:2
-
4高立伟,闫江涛,左一凡,武素芳,骆丽娜,兰守丽.紫杉醇联合顺铂治疗难治型小细胞肺癌的疗效观察[J].肿瘤基础与临床,2012,25(3):211-213. 被引量:4
-
5李俊,郭晓红,孙爱华,何樱,袁霞.吉西他滨维持治疗晚期非小细胞肺癌的疗效分析[J].中国医药科学,2012,2(13):74-75. 被引量:2
-
6刘华,王蔚,郑垂志,邢雪花,麦泽峰.诺维本联合顺铂方案治疗晚期非小细胞肺癌[J].中国肿瘤,2002,11(7):433-434. 被引量:1
-
7王勇,张晶晶,李珊,武洋,阮翊.胃癌同时性肝转移外科手术治疗的价值[J].中国实用医刊,2013,40(20):77-79. 被引量:2
-
8陈俊,郭建新,陶庆松,黄佳,王锡恩,黄敏霞.单药泰素帝周方案治疗老年晚期非小细胞肺癌疗效观察[J].江西医药,2008,43(1):6-8. 被引量:1
-
9孙宝信,张晶晶,李青山,高东奇,李爱科,宋殿宾.沙利度胺治疗老年晚期原发性肝癌的疗效[J].中国老年学杂志,2013,33(15):3752-3753. 被引量:10
-
10邬德东,杨芬,姚定珠.多西他赛维持治疗晚期非小细胞肺癌的临床观察[J].陕西医学杂志,2013,42(10):1398-1399.